Ascend Clinical Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Ascend Clinical's estimated annual revenue is currently $50.2M per year.(i)
  • Ascend Clinical's estimated revenue per employee is $297,000

Employee Data

  • Ascend Clinical has 169 Employees.(i)
  • Ascend Clinical grew their employee count by 5% last year.

Ascend Clinical's People

NameTitleEmail/Phone
1
VP Human ResourcesReveal Email/Phone
2
EVP SalesReveal Email/Phone
3
VP, Revenue CycleReveal Email/Phone
4
VP Quality AssuranceReveal Email/Phone
5
Compliance OfficerReveal Email/Phone
6
VP Business OperationsReveal Email/Phone
7
Director, Client SupportReveal Email/Phone
8
Chief Operating OfficerReveal Email/Phone
9
Marketing DirectorReveal Email/Phone
10
Chief Information OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.3M156-3%N/AN/A
#2
$148.5M440N/AN/AN/A
#3
$124.2M36846%N/AN/A
#4
$545.1M144217%N/AN/A
#5
$29.2M1086%N/AN/A
#6
$12.9M53N/AN/AN/A
#7
$1125.1M29146%$20.4MN/A
#8
$15.3M6315%N/AN/A
#9
$8.9M415%N/AN/A
#10
$4.3M23-15%N/AN/A
Add Company

What Is Ascend Clinical?

Ascend Clinical, LLC is the nation's leading and fastest growing provider of ESRD laboratory testing and electronic information delivery services to independent dialysis providers. In addition to accurate, reliable and efficient renal laboratory testing, the company also develops and markets Web-based software (SaaS) that enables dialysis clinics to efficiently operate and manage patient care. Formerly Satellite Laboratory Services, the company is privately held and headquartered in Redwood City, CA, with software development located in Denver, CO. Employing over 200 people across 23 states to serve independent dialysis providers and hospital-based clinics, Ascend Clinical serves the 50 United States and its territories. The company was named one of the Bay Area's Top Workplaces.

keywords:N/A

N/A

Total Funding

169

Number of Employees

$50.2M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Ascend Clinical News

2022-04-17 - After rivals' FDA rebuffs, GSK targets class-first oral approval ...

Daprodustat's application, meanwhile, leverages data from GSK's Ascend phase 3 clinical program, which covered five pivotal trials weighing the safety and...

2022-04-17 - FDA Accepts New Drug Application for Daprodustat as ...

The application is based on positive results from the ASCEND phase 3 clinical trial, assessing the efficacy and safety of daprodustat for...

2022-04-17 - Ascend Wellness Expands to Pennsylvania with $55 Million ...

Story received a Clinical Registrant permit (“Permit”) from the Pennsylvania Department of Health on March 1, and Story will remain the...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$54.5M17118%N/A
#2
$62.2M174-2%N/A
#3
$27.3M1759%$294M
#4
$28.1M1762%N/A
#5
$52.3M17611%N/A